Literature DB >> 7776085

Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.

R N Husson1, Y Lan, E Kojima, D Venzon, H Mitsuya, K McIntosh.   

Abstract

OBJECTIVE: To evaluate immunologic and virologic correlates of vertical transmission of human immunodeficiency virus type 1 (HIV-1).
DESIGN: Case-control study. PATIENTS: Women who were prospectively enrolled in a natural history study of HIV-1 infection in women and infants. Sixteen HIV-1-infected women whose infants became infected were matched by CD4+ cell percentage and use of zidovudine during pregnancy with women whose infants did not become infected. MEASUREMENTS: Maternal autologous neutralizing antibody, virus load determined by RNA-polymerase chain reaction (RNA-PCR), and virus phenotype.
RESULTS: Most women in both groups had low titers of autologous neutralizing antibody, and no difference in neutralizing titers was observed (range, < 4 to 181 in both groups). The HIV-1 copy number in maternal plasma was not significantly different in the two groups but was inversely correlated with maternal CD4+ cell percentage (p < 0.005). Five women in the transmitting group and four in the non-transmitting group had syncytium-inducing (SI) phenotype virus. Two infected infants had SI phenotype virus. The SI phenotype virus was associated with a greater HIV-1 copy number in maternal plasma (p < 0.05) and an increase in the mortality rate for the infants (p < 0.01).
CONCLUSIONS: In women matched for CD4+ cell percentage, low titers of autologous neutralizing antibody, high virus load, and SI phenotype virus were not associated with an increased risk of transmission of HIV-1 to their infants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776085     DOI: 10.1016/s0022-3476(95)70198-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope.

Authors:  Leslie Goo; Caitlin Milligan; Cassandra A Simonich; Ruth Nduati; Julie Overbaugh
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.

Authors:  Ruth Dickover; Eileen Garratty; Karina Yusim; Catherine Miller; Bette Korber; Yvonne Bryson
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.

Authors:  C C Wilson; R C Brown; B T Korber; B M Wilkes; D J Ruhl; D Sakamoto; K Kunstman; K Luzuriaga; I C Hanson; S M Widmayer; A Wiznia; S Clapp; A J Ammann; R A Koup; S M Wolinsky; B D Walker
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 5.  Mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  G C John; J Kreiss
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

6.  Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

Authors:  R E Dickover; E M Garratty; S Plaeger; Y J Bryson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.

Authors:  Maxwel M Omenda; Caitlin Milligan; Katherine Odem-Davis; Ruth Nduati; Barbra A Richardson; John Lynch; Grace John-Stewart; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

8.  HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Authors:  Jennifer Mabuka; Ruth Nduati; Katherine Odem-Davis; Dylan Peterson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

9.  HIV-1 autologous antibody neutralization associates with mother to child transmission.

Authors:  Elly Baan; Anthony de Ronde; Martijn Stax; Rogier W Sanders; Stanley Luchters; Joseph Vyankandondera; Joep M Lange; Georgios Pollakis; William A Paxton
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

10.  Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.

Authors:  Caitlin Milligan; Maxwel M Omenda; Vrasha Chohan; Katherine Odem-Davis; Barbra A Richardson; Ruth Nduati; Julie Overbaugh
Journal:  mBio       Date:  2016-02-02       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.